Order against NextMed over deceptive ads gets final nod
The Federal Trade Commission announced the final approval of an order against telemedicine company NextMed. It requires the company to stop deceptive ads of weight-loss programs and end unfair billing and...To view the full article, register now.
Already a subscriber? Click here to view full article